An open label pilot study of Zoledronate (Aclasta 5mg iv) in the treatment of Ankylosing Spondylitis.
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2014
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 15 Sep 2014 Results presented at the 36th Annual Meeting of the American Society for Bone and Mineral Research.
- 09 Jun 2011 New trial record